Antimicrobial Susceptibility of Ceftazidime-Avibactam in Clinical Isolates of Carbapenemase-Producing Enterobacterales
Ceftazidime-avibactam shows excellent activity against class A carbapenemase-producing Enterobacterales but limited efficacy against MBL producers. The combination with aztreonam significantly enhances activity against MBL-producing strains which suggests a possible way to treat infections caused by these tough bacteria.
Authors
- Sarita Jain
- Anamika Vyas
- Parul Chaturvedi
Institutions
- Rabindranath Tagore Medical College (IN)
Publication Details
- Journal
- Cureus
- Published
- 2025-09-21
- DOI
- https://doi.org/10.7759/cureus.92889
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00